Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ensemble Therapeutics Corp.

www.ensembletx.com

Latest From Ensemble Therapeutics Corp.

Novartis Targets Leading MS Role With Gilenya, BAF312 And IL-17 Pathway

Novartis aims to build a leading role in multiple sclerosis by developing new agents now in Phase III, progressing promising early stage assets and by using new technologies to measure the disease.

BioPharmaceutical Switzerland

Deciphera Readies For Next Steps; Brings Third Compound Into Phase I

The newly relocated biotech is shifting its focus from science to business development as it moves its third compound into the clinic and begins looking for partners for its other programs.

BioPharmaceutical North America

IL-17: Pushing The Limits Of A Drug Target

A series of recent and anticipated events is drawing attention to interleukin-17 and related cytokines – a set of immunological drug targets of long-standing interest to large and small companies. The current crop of big-company candidates are biologics and may prove too harsh for all but the most severe immunological conditions, leaving room for start-ups developing small molecules.

BioPharmaceutical Research and Development Strategies

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Ensemble Discovery Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ensemble Therapeutics Corp.
  • Senior Management
  • Michael D Taylor, PhD, Pres. & CEO
    Nick K Terrett, PhD, CSO
    Andrea Szekely-Hill, Sr. Dir., Fin. & Admin.
    Ted Hibben, SVP, Corp. Dev.
  • Contact Info
  • Ensemble Therapeutics Corp.
    Phone: (617) 492-6977
    99 Erie St.
    Cambridge, MA 02139-4535
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register